NYSE : DHR

Danaher Corporation

$203.83 USD

-$1.18 (-0.58%)

Volume
4.87M
Average Volume
4.66M
Market Capitalization
$144.26B
P/E Ratio
39.27
Dividend Yield
0.71%
Price Target
$230.00
Year High
$242.80
Year Low
$160.93
Day High
—
Day Low
—
Payout Ratio
$0.25
Current Ratio
$1.87
Company Overview

NYSE

Rainer Blair

Medical - Diagnostics & Research

Healthcare

DHR

61000

US

USD

https://www.danaher.com

202 828 0850

235851102

0000313616

Liquidity Metrics

0.35

1.87

1.52

0.76

0.25

Sales & Valuation

$24.57B

5.82

2.73

27.27

7.47

Profitability

$5.04

$3.61B

14.89%

17.51%

7.06%

4.42%

P/E Metrics

39.27

1768725842094274.20

1768725842094274.20

Analyst Price Target & Rating

$230.00

$249.00

$200.00

Neutral

3/5

43 Analysts

-11.38%

Poll Results

About Danaher Corporation (NYSE:DHR) Stock

Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers ... bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.

Will Danaher (DHR) Beat Estimates Again in Its Next Earnings Report?

2026-07-16 13:11:05

Danaher (DHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Danaher Gears Up to Post Q2 Earnings: Is a Beat in the Offing?

2026-07-16 12:51:08

DHR heads into Q2 earnings with bioprocessing and diagnostics strength, but rising costs and debt could pressure profitability.

Countdown to Danaher (DHR) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS

2026-07-16 10:36:44

Besides Wall Street's top-and-bottom-line estimates for Danaher (DHR), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2026.

Implied Volatility Surging for Danaher Stock Options

2026-07-14 16:41:20

Investors need to pay close attention to DHR stock based on the movements in the options market lately.

Danaher (DHR) Reports Next Week: Wall Street Expects Earnings Growth

2026-07-14 11:01:06

Danaher (DHR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Abbott Labs Vs. Danaher: Abbott's Everyday Products Beat Danaher's Slumping Biotech Equipment

2026-07-10 14:18:48

Abbott Laboratories (NYSE:ABT | ABT Price Prediction) and Danaher (NYSE:DHR) both closed the books on Q1 2026 with very different stories.

VTRS or DHR: Which Is the Better Value Stock Right Now?

2026-07-09 12:40:44

Investors interested in Medical Services stocks are likely familiar with Viatris (VTRS) and Danaher (DHR). But which of these two companies is the best option for those looking for undervalued stocks?

Will Strength in Biotechnology Unit Continue to Drive DHR's Growth?

2026-07-08 12:51:04

Danaher's Biotechnology segment posts 7% core revenue growth as bioprocessing demand strengthened, even as weaker product demand created headwinds.

Frequently Asked Questions

What is the current Danaher Corporation (DHR) stock price?

Danaher Corporation(NYSE:DHR) stock price is $203.83 in the last trading session. During the trading session, DHR stock reached the peak price of $242.8 while $160.93 was the lowest point it dropped to. The percentage change in DHR stock occurred in the recent session was --0.58% while the dollar amount for the price change in DHR stock was -$1.18.

DHR's industry and sector of operation?

The NYSE listed DHR is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector.

Who are the executives of DHR?

Jose-Carlos Gutierrez-Ramos | Senior Vice President & Chief Science Officer
Matthew R. McGrew | Executive Vice President
Julie Sawyer Montgomery | Executive Vice President of Diagnostics Platform
Rainer Blair | President, Chief Executive Officer & Director
Mitchell Rales | Co-Founder & Director

How many employees does DHR have?

Number of DHR employees currently stands at 61000. DHR operates from 2200 Pennsylvania Avenue, NW, Washington, DC 20037-1701, US.

Link for DHR official website?

Official Website of DHR is: https://www.danaher.com

How do I contact DHR?

DHR could be contacted at phone #202 828 0850 and can also be accessed through its website. DHR operates from 2200 Pennsylvania Avenue, NW, Washington, DC 20037-1701, US.

How many shares of DHR are traded daily?

The average number of DHR shares traded daily for last 3 months was 4.66M.

What is the market cap of DHR currently?

The market value of DHR currently stands at $144.26B with its latest stock price at $203.83